- Home
- CRBP vs MYFW Comparison
CRBP vs MYFW Comparison
Compare CRBP & MYFW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- MYFW
- Stock Information
- Founded
- CRBP 2009
- MYFW 2002
- Country
- CRBP United States
- MYFW United States
- Employees
- CRBP N/A
- MYFW N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- MYFW Major Banks
- Sector
- CRBP Health Care
- MYFW Finance
- Exchange
- CRBP Nasdaq
- MYFW Nasdaq
- Market Cap
- CRBP 143.7M
- MYFW 170.9M
- IPO Year
- CRBP N/A
- MYFW 2018
- Fundamental
- Price
- CRBP $11.93
- MYFW $18.28
- Analyst Decision
- CRBP Strong Buy
- MYFW Buy
- Analyst Count
- CRBP 8
- MYFW 3
- Target Price
- CRBP $62.00
- MYFW $22.33
- AVG Volume (30 Days)
- CRBP 256.8K
- MYFW 20.1K
- Earning Date
- CRBP 03-11-2025
- MYFW 01-23-2025
- Dividend Yield
- CRBP N/A
- MYFW N/A
- EPS Growth
- CRBP N/A
- MYFW N/A
- EPS
- CRBP N/A
- MYFW 0.26
- Revenue
- CRBP N/A
- MYFW $79,649,000.00
- Revenue This Year
- CRBP N/A
- MYFW N/A
- Revenue Next Year
- CRBP N/A
- MYFW $12.86
- P/E Ratio
- CRBP N/A
- MYFW $69.95
- Revenue Growth
- CRBP N/A
- MYFW N/A
- 52 Week Low
- CRBP $7.30
- MYFW $12.84
- 52 Week High
- CRBP $61.90
- MYFW $22.32
- Technical
- Relative Strength Index (RSI)
- CRBP 39.08
- MYFW 40.92
- Support Level
- CRBP $11.02
- MYFW $17.53
- Resistance Level
- CRBP $13.28
- MYFW $18.05
- Average True Range (ATR)
- CRBP 0.74
- MYFW 0.66
- MACD
- CRBP 0.16
- MYFW -0.03
- Stochastic Oscillator
- CRBP 40.27
- MYFW 44.53
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.